ZR-CHOP in DLBCL With Specific Gene Abnormality

NCT05290337 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

62

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Large B Cell Lymphoma

Interventions

DRUG: zanubrutinib

Sponsor

Fudan University